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Viral pathogen discovery
Charles Y Chiu1,2
Available online at www.sciencedirect.comViral pathogen discovery is of critical importance to clinical
microbiology, infectious diseases, and public health. Genomic
approaches for pathogen discovery, including consensus
polymerase chain reaction (PCR), microarrays, and unbiased
next-generation sequencing (NGS), have the capacity to
comprehensively identify novel microbes present in clinical
samples. Although numerous challenges remain to be
addressed, including the bioinformatics analysis and
interpretation of large datasets, these technologies have been
successful in rapidly identifying emerging outbreak threats,
screening vaccines and other biological products for microbial
contamination, and discovering novel viruses associated with
both acute and chronic illnesses. Downstream studies such as
genome assembly, epidemiologic screening, and a culture
system or animal model of infection are necessary to establish
an association of a candidate pathogen with disease.
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Introduction
The identification of novel pathogens has a tremendous
impact on infectious diseases, microbiology, and human
health. Nearly all of the outbreaks of clinical and public
health importance over the past two decades have been
caused by novel emerging viruses, including Severe
Acute Respiratory Syndrome (SARS) coronavirus [1],
Sin Nombre hantavirus [2], 2009 pandemic influenza
H1N1 [3,4], and the recently described coronavirus
EMC [5–7] and H7N9 avian influenza viruses [8], with
Open access under CC BY license.Current Opinion in Microbiology 2013, 16:468–478 most originating from animal reservoirs. Changes in the
environment, globalization, growth of wet (live animal)
markets, and the rapid expansion of the human popu-
lation into wildlife habitats all promote the rapid spread of
previously unidentified pathogens that are capable of
causing widespread and devastating epidemics of human
illness [9]. Arthropods such as mosquitoes and ticks are
vectors for emerging pathogens including West Nile virus
[10,11], and the Severe Fever and Thrombocytopenia
Syndrome (SFTS) [12,13] and Heartland bunyaviruses
[14]. Moreover, the link between new viruses and disease
is not only restricted to acute illnesses, but also can be
seen in chronic disease states, as demonstrated by the
strong association between infection by the novel Merkel
cell polyomavirus (MCPyV) and a rare, highly aggressive
skin tumor in elderly patients [15].
Currently available diagnostic tests for pathogens are
generally narrow in scope and fail to detect an agent in
a significant fraction of cases. Traditional methods such as
culture, serology, or targeted nucleic acid-based testing,
such as specific polymerase chain reaction (PCR), have
limited utility in investigations where there is no a priori
knowledge of the identity of potential infectious agents.
Notably, in certain infectious diseases such as encepha-
litis, conventional testing fails to identify a pathogen in up
to 70% of cases [16–18]. In contrast, state-of-the-art
genomic technologies such as pan-microbial microarrays
or unbiased next-generation sequencing (NGS) can be
attractive tools for broad-based pathogen discovery.
Nearly all infectious agents, with the sole exception of
prions [19], contain either RNA or DNA, and are thus
amenable to nucleic acid-based detection. In principle,
these technologies are capable of comprehensively iden-
tifying all potential pathogens in clinical samples from
humans and animals. This review will describe the geno-
mic approaches for pathogen discovery currently being
employed in the field, and highlight recent examples of
their use in the discovery and characterization of novel
viral pathogens (Table 1).
Genomic approaches for pathogen discovery
Pathogen discovery entails the use of genomic-based
methods to identify novel microbes, followed by further
investigation to determine potential associations with dis-
ease (Figure 1). As a pathogen discovery tool, consensus
PCR uses degenerate primers to detect conserved
sequences that are broadly shared between members of
a group. This approach was recently used to identify novel
paramyxoviruses in samples from large-scale surveys of
bats and rodents [20–22] and emerging viruses such
as coronavirus EMC, the cause of a new severe andwww.sciencedirect.com
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Table 1
Some recent examples of viral pathogen discoveryd
Namea Detection platform NGS bioinformatics approach Disease assocation Strength of
associationc
Coronavirus-EMC Culture and 454 NGS [7] De novo genome assembly Severe pneumonia (humans) ++
SFTS (severe fever with
thrombocytopenia virus)
bunyavirus [12,13]
Illumina NGS [12] Subtraction and BLAST
search
Severe fever with
thrombocytopenia
++
Heartland bunyavirus Culture and 454 NGS [14] BLAST search and de novo
gene assembly
Severe febrile illness ++
MCPyV (Merkel cell
polyomavirus)
454 NGS [15] Subtraction and BLAST
search
Merkel cell carcinoma (MCC) ++
Bat paramyxoviruses Consensus PCR [20–22] N/A – –
Raccoon polyomavirus Consensus PCR and RCA [38] N/A Brain tumors (racoons) ++
HPyV6 and HPyV7 (human
polyomaviruses 6 and 7)
RCA [39] N/A N/A –
TSPyV (trichodysplasia
spinulosa-associated
polyomavirus)
RCA [40] N/A Trichodysplasia spinulosa ++
2009 pandemic influenza
A(H1N1)b
Microarray and Illumina NGS
[51]
Subtraction and BLAST
search
Febrile illness ++
454 NGS [110,111] BLAST search Febrile illness ++
Illumina NGS [112] BLAST search Febrile illness ++
TMAdV (titi monkey adenovirus) Microarray and Illumina NGS
[52]
BLAST search Pneumonia (titi monkeys) ++
BASV (Bas-Congo virus),
a rhabdovirus
Illumina NGS [58] Subtraction, BLAST search,
and de novo genome
assembly
Acute hemorrhagic fever ++
Novel circoviruses and
cycloviruses in humans
and monkeys
454 NGS [59] Subtraction and BLAST
search
Diarrhea –
Human klassevirus/salivirus Illumina NGS [61] Subtraction and BLAST
search
Diarrhea –
454 NGS [60,62] Subtraction and BLAST
search
Diarrhea –
MWPyV/HPy10/MXPyV
(MW polyomavirus)
454 NGS [63] Subtraction and BLAST
search
Diarrhea –
Illumina NGS [64] Subtraction and BLAST
search
Diarrhea –
Illumina NGS [65] BLAST search WHIM syndrome –
HPyV9 (human polyomavirus 9) Illumina NGS [66] Subtraction and BLAST
search
– –
Consensus PCR [24] N/A – –
Human bufavirus 454 NGS [67] Subtraction and BLAST
search
Diarrhea –
HAstV-PS (human astrovirus
Puget Sound)
454 NGS [68] Subtraction and BLAST
search
Encephalitis ++
Human enterovirus 109 Consensus PCR and Illumina
NGS [69]
Subtraction and BLAST
search
Acute respiratory illness +
Dandenong arenavirus 454 NGS [70] Subtraction and BLAST
search
Fatal febrile illness in
transplant patients
++
Lujo arenavirus 454 NGS [71] Subtraction and BLAST
search
Acute hemorrhagic fever ++
TDAV (Theiler’s
disease-associated
virus), a novel pegivirus
Illumina NGS [73] BLAST search and de novo
genome assembly
Hepatitis (horses) ++
Bat, canine, horse, and
rodent hepaciviruses
and pegiviruses
454 NGS [74–77] BLAST search Respiratory infection (dogs) –
Canine bocavirus 3 Illumina NGS [78] BLAST search Hemorrhagic diarrhea and
vasculitis (dog)
–
Snake arenaviruses Illumina NGS [79] Subtraction and BLAST
search
Inclusion body disease
(snakes)
++
www.sciencedirect.com Current Opinion in Microbiology 2013, 16:468–478
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Table 1 (Continued )
Namea Detection platform NGS bioinformatics approach Disease assocation Strength of
associationc
SAdV-C (simian adenovirus C) Culture and Illumina NGS
[105]
BLAST search and de novo
genome assembly
Pneumonia (baboons) ++
Acute respiratory illness
(humans)
+
a Viruses were detected in clinical samples from humans unless otherwise specified.
b Discovered previously in 2009 by conventional testing [3,4].
c –, unknown or no association observed with the given disease; +, moderate association; ++, strong association.
d Viruses are listed in order in which they are first mentioned. Note that table is not comprehensive and only lists viruses that are specifically
highlighted in the text. Abbreviations: NGS, next-generation sequencing; 454, Roche 454 pyrosequencing platform; PCR, polymerase chain reaction;
RCA, rolling circle amplification; subtraction, computational ‘digital’ subtraction of host background sequences from NGS data; BLAST, basic local
alignment search tool; WHIM syndrome, Warts, Hypogammaglobulinemia, Infections, and Myelokathexis syndrome; N/A, not applicable.occasionally fatal respiratory disease in the Middle East
and Europe [6], although many other examples of this
strategy for viral discovery exist [23,24]. However, the
identity of an infectious agent is often not known a priori,
and a random, unbiased, and sequence-independent
method for ‘universal’ amplification becomes necessary
for pathogen discovery [25]. In the past, such universal
amplification methods have been used in combination with
conventional shotgun Sanger sequencing to detect novel
human viruses such as human metapneumovirus in respir-
atory secretions [26], PARV4, a novel parvovirus in blood
from patients with acute viral infection syndrome [27], and
novel astroviruses, parvoviruses, picornaviruses (cardio-
viruses and cosaviruses), and polyomaviruses in diarrheal
stool [25,28–34]. One caveat with this approach may be the
relatively low detection sensitivity of 106 genome equiva-
lents per milliliter [25]. A related strategy is the use of
rolling circle amplification (RCA) [35,36], which has been
successful in the unbiased detection and/or characteriz-
ation of DNA viruses with circular genomes, such as novel
papillomaviruses, circoviruses, and polyomaviruses [37–
40].
DNA microarrays have been used for multiplexed detec-
tion of a defined set of known pathogens using conserved
primers [41], or for broad pan-microbial detection by
universal amplification [42–44]. Microarrays are miniatur-
ized detection platforms consisting of short (25-mer to 70-
mer) single-stranded oligonucleotide probes deposited
onto a solid substrate. These probes are typically
designed to target conserved sequences at different levels
of the taxonomy (family, genus, and species), which
allows detection of novel pathogens that share homology
with known, previously characterized viruses. Fluores-
cently labeled clinical samples are hybridized to the
microarray, and hybridization patterns are analyzed to
identify the specific pathogens that are present
(Figure 2a) [43–47].
Pan-microbial DNA microarrays currently in use include
the ViroChip (University of California, San Francisco)
[42,48], GreeneChip (Columbia University) [43], and the
Lawrence Livermore Microbial Detection Array, orCurrent Opinion in Microbiology 2013, 16:468–478 LLMDA (Lawrence Livermore National Laboratory)
[44]. The ViroChip is a pan-viral DNA microarray and
was originally employed to characterize the coronavirus
responsible for the 2003 outbreak of SARS [1]. Since then,
studies have employed the ViroChip to discover a number
of novel viruses including a previously undescribed rhi-
novirus clade [49], human cardioviruses [50], and 2009
pandemic influenza H1N1 (Figure 2a) [51]. In 2011, the
ViroChip was also used to identify a novel adenovirus that
caused a fulminant pneumonia outbreak in a New World
titi monkey colony, with serologic evidence of concurrent
cross-species infection of a human researcher [52]. The
GreeneChip is a pan-microbial array that includes 30k
60-mer probes and is designed to broadly detect all
viruses, as well as pathogenic bacteria, fungi, and protozoa
on the basis of conserved 16S/18S sequences [43]. The
LLMDA is yet another comprehensive pan-microbial
detection array that targets all potential pathogens, with
probes derived from their full genome sequences [44].
The GreeneChip and LLMDA have been used to detect
Plasmodium falciparum in a patient with an unknown
febrile illness [43] and porcine circovirus as a contaminant
in a rotavirus vaccine [53], respectively. Although useful
for the detection of a wide spectrum of pathogens, and for
the detection of novel strains, microarrays are still limited
by the genome sequence information available at the
time of design.
NGS, otherwise known as massively parallel or deep
sequencing, has emerged as one of the most promising
strategies for the detection of novel infectious agents in
clinical specimens [54,55]. This ‘needle-in-a-haystack’
approach involves analysis of millions of sequences
derived from nucleic acid present in clinical specimens
to detect sequences corresponding to candidate patho-
gens. Given low amounts of input nucleic acid in clinical
samples, an unbiased, random method employing uni-
versal amplification is typically performed during NGS
library generation [25,56], similar to that used in pan-
microbial microarray assays [42]. Because of its unbiased
nature, NGS can identify both known but unexpected
agents and highly divergent novel agents. NGS is thus
particularly attractive for the identification of novelwww.sciencedirect.com
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Genomic approaches to pathogen discovery. Clinical samples are
subjected to pathogen enrichment and host depletion methods,
followed by genomic analysis using consensus PCR, pan-microbial
microarrays, and/or NGS. After a novel agent is identified, downstream
studies are needed to establish a causal association between the
candidate pathogen and disease.emerging viruses, which can exhibit high inherent
sequence diversity and rapid rates of mutation, recombi-
nation, or reassortment [57]. For example, NGS was
recently used to identify and recover the genome of a
novel, highly divergent rhabdovirus, Bas-Congo virus
(BASV), associated with a 2009 hemorrhagic fever out-
break in the Congo, Africa (Figure 3a) [58]. In this study,
the genome of BASV was de novo assembled from 140
million deep sequencing reads corresponding to an acutewww.sciencedirect.com serum sample from an affected patient (Figure 3b). The
discovery of BASV underscores the potential of NGS in
facilitating early identification of pathogens causing
unknown outbreaks in remote areas of the world before
they gain a foothold in human populations.
In addition to the identification of BASV, the use of NGS
technology has led to the discovery of many novel human
viruses over the past decade, including, among others, the
aforementioned MCPyV [15]; novel circoviruses/cyclo-
viruses [59], kobuviruses (klassevirus/salivirus) [60–62];
polyomaviruses such as the HPyV9 and MWPyV/
HPyV10/MXPyV [63–66]; a novel parvovirus named bufa-
virus [67]; a novel astrovirus associated with encephalitis
[68]; a novel enterovirus species in tropical febrile illness
[69]; as well as novel arenaviruses in a fatal outbreak of
transplant recipients [70] and a hemorrhagic fever outbreak
from South Africa [71]. In 2011, an unknown outbreak of
fever and thrombocytopenia involving hundreds of
patients occurred in rural China [12,13]. Unbiased NGS
of pooled patient serum samples was used by one research
group to identify the causal agent as a novel, highly
divergent bunyavirus in the Phlebovirus genus referred to
as Severe Fever and Thrombocytopenia Syndrome
(SFTS) virus [12]. Furthermore, NGS has been used to
enable whole-genome sequencing and assembly of highly
divergent viruses identified from unknown cultures exhi-
biting cytopathic effect. Heartland virus, a presumed novel
tick-borne bunyavirus in the Phlebovirus genus associated
with two cases of severe febrile illness in hospitalized
patients in Missouri [14], and Lone Star virus, another
phlebovirus infecting the Amblyomma americanum tick [72],
were both successfully sequenced from virally infected cell
culture supernatants using NGS.
NGS approaches have also been successful in the identi-
fication of novel animal viruses, including the discovery of
bats, dogs, horses, and rodents as reservoirs for novel
flaviruses (pegiviruses and hepaciviruses distantly related
to human hepatitis C) [73–77], a novel bocavirus in canine
liver [78], and novel arenaviruses associated with inclusion
body disease in snakes [79]. Recently, a novel flavivirus in
the Pegivirus genus, named Theiler’s disease-associated
virus (TDAV), was found by NGS to be the likely cause of
an mysterious acute hepatitis in horses associated with the
administration of equine blood products, a diagnosis that
had eluded microbiologists for nearly a century [73].
Finally, infection by non-viral agents, such as Fusobacter-
ium nucleatum bacteria in the setting of colon cancer, has
also been detected by NGS [80].
Sample preparation methods
Both unbiased NGS, and, to a lesser extent, pan-microbial
microarrays are affected by the level of host background,
limiting sensitivity for detection of pathogen-derived
sequences. In a study using NGS to investigate occult
bacterial infection in tissues, microbial sequences wereCurrent Opinion in Microbiology 2013, 16:468–478
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Microarray and NGS analyses of pandemic 2009 influenza A(H1N1) infection in humans. (a) Heat map of ViroChip microarray hybridization patterns
obtained from nasal swab samples from patients with influenza-like illness and asymptomatic negative controls (‘neg’). The samples (x-axis) and
microarray probes (y-axis) are clustered using a hierarchical clustering algorithm [45]. High-intensity probes derived from swine influenza A(H1N1) and
human influenza A(H1N1) sequences are observed in samples from patients infected by pandemic 2009 influenza A(H1N1), with higher relative signal
intensity in the swine influenza A(H1N1) probes. In contrast, the ViroChip signature in nasal swabs from patients infected with seasonal H3N2 influenza
consists primarily of influenza A(H3N2) probes. No microarray cross-hybridization is observed in patients infected with other respiratory viruses or
negative controls. Note that the influenza probes on the ViroChip microarray shown here were designed before onset of the pandemic 2009 influenza
A(H1N1) outbreak. (b) Computational pipeline for analysis of NGS data. Preprocessing and computational subtraction of host (human) sequences are
then followed by alignment to pathogen reference databases. The percentages show the remaining proportion of reads after each step, beginning with
100% of the preprocessed reads. Abbreviations: DBs, databases; rRNA, ribosomal RNA; mRNA, messenger RNA.
Modified from [51] with permission.only detected in 0.00067% of NGS reads, corresponding
to fewer than 10 per million [80]. Pathogen enrichment or
host depletion before microarray and deep sequencing
analyses hence becomes critical to maximize sensitivity
for identification of novel agents in clinical samples
(Figure 1). For viruses, capsid purification procedures
involving repeated freeze/thaw cycles, filtration, ultracen-
trifugation, and prenuclease digestion have been devel-
oped to enrich host tissues or body fluids for infectious
particles [78,81]. Strategies to deplete the sample of
background host DNA can also be implemented, in-
cluding the use of methylation-specific DNAse to selec-
tively degrade host genomes [82], removal of host
ribosomal RNA [83], and/or removal of the most abundant
host sequences by duplex-specific nuclease (DSN) nor-
malization [84]. Another complementary approach is toCurrent Opinion in Microbiology 2013, 16:468–478 perform target enrichment using biotinylated probes to
enrich NGS libraries for sequences corresponding to
pathogens, akin to now well-established techniques that
have been developed in the cancer field [85]. This
strategy can also potentially harness prior experience with
microarrays for pathogen discovery by the use of pre-
viously validated microarray probes to enrich NGS
libraries for microbial sequences.
The choice of NGS platforms on the market today for
pathogen discovery is driven by two main parameters:
read length and read depth. NGS reads must be long
enough (typically at least 100–300 nt) to unambiguously
identify the presence of a novel pathogen, and to dis-
criminate reads from host or background flora. There
must also be sufficient read depth, or number of sequencewww.sciencedirect.com
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Figure 3
de novo assembly of 140 million NGS reads 
2
3
5
6
7
8
9
4
manual trimming and assembly 
(50%)
(51%)
(60%)
(61%)
(73%)
(82%)
(84%)
(86%)
(71%)
(64%)
Initial detection of single rhabdovirus read aligning to rhabdoviruses
1
10
100
1000
10000
2 4 6 8 10 12 kb1 3 5 7 9 11
10
BASV genome coverage
(98%)
Rabies
virus
25.0% overall amino acid identity
1
BASV
Ebola
Marburg
Lassa
Crimean-Congo
Lujo
(a) (b)
Current Opinion in Microbiology
cycle
Discovery of Bas-Congo virus (BASV), a novel rhabdovirus associated with acute hemorrhagic fever in humans. (a) Map of Africa showing viral
hemorrhagic fever outbreak regions. Hemorrhagic fever due to flaviviruses, such as dengue and yellow fever, is widespread throughout the continent.
The location of the BASV hemorrhagic fever outbreak is designated by a red star. (b) Deep sequencing and de novo genome assembly of BASV. The
BASV genome is highly divergent, sharing only 25% amino acid identity with rabies and <42% amino acid identity with any other rhabdovirus.
Modified from [58] with permission.reads generated per run, to detect novel agents with a
high degree of sensitivity. For pathogen discovery, the
Roche 454 GS-FLX+pyrosequencingTM platform has
been widely applied given the long reads (currently up
to 1 million single or paired-end reads with average read
lengths of 400–500 nt with the GS-FLX+ TitaniumTM
platform) and high accuracy. More recently, Illumina
NGS sequencing platforms (GAIIxTM, HiSeqTM, and
MiSeqTM) have been used for pathogen discovery given
the 10–1000 improved read depth relative to 454,
resulting in much greater sensitivity for the detection
of viruses [86], and gradually improving read lengths
(currently up to 150 nt paired-end reads for the HiSeq
and 250 nt paired-end reads for the MiSeq). In fact,
previous studies suggest that the limits of detection of
viruses in clinical samples by NGS with Illumina sequen-
cing are comparable to specific PCR [51,86]. The use of
paired-end sequencing, or sequencing from each end of
the DNA fragment in NGS libraries, can be particularly
useful for pathogen discovery given that the forward and
reverse reads can facilitate the design of PCR primers to
confirm potential sequence ‘hits’ to novel microbes and de
novo genome assembly [87]. Other NGS technologies,www.sciencedirect.com such as platforms by Ion Torrent (very fast run times of
under three hours) and Pacific Biosciences (very long
reads of up to 7 kb; average read lengths 3–4 kb) [88],
have yet to be used widely for pathogen discovery,
although one application may be rapid genome sequen-
cing of emerging pathogens such as Escherichia coli
O104:H4, associated with a recent foodborne outbreak
of hemolytic-uremic syndrome in Germany [89,90]. One
particular concern for all unbiased NGS technologies is
the high potential for reagent and laboratory contami-
nation, especially with the use of universal amplification
methods [51,86,91].
Bioinformatics analysis challenges
Whereas for microarrays, specialized bioinformatics algor-
ithms for pathogen detection are in routine use [43–47],
analysis of NGS data for pathogen discovery poses enor-
mous computational challenges. The most widely used
strategy is computational subtraction, in which reads are
first sequentially aligned to reference databases to filter out
sequences corresponding to host background [92].
Sequences derived from microbes are then typically ident-
ified by nucleotide or translated amino acid alignmentsCurrent Opinion in Microbiology 2013, 16:468–478
474 Host–microbe interactions: virusesusing BLAST [93]. This approach was previously used, for
example, to detect pandemic 2009 influenza A(H1N1) in
nasal swabs from affected patients with respiratory illness
(Figure 2b) [51]. For highly divergent viruses, successful
identification can sometimes only be made by searching for
remote homologs of protein sequences using methods such
as HMMER [94,95]. Dedicated bioinformatics analysis
pipelines, such as PathSeq, used to detect Fusobacterium
bacteria in colon cancer tissues [80], RINS, CaPSID, and
READSCAN are now available for automated pathogen
identification from NGS data [96–99], although their per-
formance has yet to be rigorously tested on a large number
of clinical samples. Ongoing limitations of available bioin-
formatics software for pathogen discovery include the data-
intensive computing workloads that are not amenable to
real-time analysis in the absence of ultra-rapid processing
algorithms, the lack of a graphical user interface, the
requirement for a minimum level of computer hardware
and bioinformatics expertise, and the lack of a validated
scoring system to permit confident identification of
microbes from NGS data. In addition, existing reference
sequence databases, such as NIH GenBank, can be heavily
baised and fraught with annotation errors. Notably, over
40% of the GenBank viral database consists of overrepre-
sented HIV or influenza sequences. Comprehensive, well-
annotated reference databases for pathogens are thusFigure 4
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Current Opinion in Microbiology 2013, 16:468–478 needed in support of NGS-based pathogen discovery
efforts.
Linking a novel pathogen to disease
The mere discovery of a candidate pathogen is only the
first step in determining whether or not it is associated
with disease. Clinical samples are colonized with a variety
of commensal organisms (the ‘microbiome’) [100], and it
is often difficult, if not impossible, to unambiguously
identify a single causal infectious agent. Highly diver-
gent, novel agents such as torque teno virus (TTV)
[101,102] may be nonpathogenic and part of the normal
microbial flora. Follow-up studies to establish causality
are thus needed to establish a link between a candidate
infectious agent and disease (Figure 1).
To assign causality, attempts should be made to address
Koch’s postulates, which require that the agent be iso-
lated in culture, or River’s modifications, which recognize
the added significance of the generation of specific anti-
bodies in response to infection [103]. For novel viruses,
this begins with assembly of the entire genome, either de
novo directly from NGS data [58,72,87] or by standard
methods such as primer walking, probe enrichment [104],
and/or specific PCR to fill in gaps [52]. Full or partial
genomic sequence permits a detailed phylogeneticDate Collected SAdV-B SAdV-C
Pre Post Pre Post
1/20/1993 5/06/1997 − 1:128 − 1:128
8/30/1988 5/06/1997 − 1:64 − 1:64
1/20/1993 5/06/1997 − 1:64 − 1:64
3/16/1993 5/06/1997 − 1:32 − 1:32
1/20/1993 5/06/1997 − − − 1:64
8/30/1 988 5/06/1997 − 1:64 − 1:64
N/A − −
N/A − −
N/A − −
N/A − −
N/A − −
el
earch facility
Pre Post
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ute respiratory outbreak in a baboon colony. A novel adenovirus, named
k at a primate research facility that sickened 4 of 9 baboons and resulted
e facility and controls (five epidemiologically unrelated young children) for
es to SAdV-C are absent before the outbreak but detected in 6 of 6 staff
Abbreviations: BAdV, baboon adenovirus; SAdV, simian adenovirus; Pre,
with permission.
www.sciencedirect.com
Viral pathogen discovery Chiu 475analysis of the novel agent, which can provide clues as to
its potential host range and pathogenicity [58]. The avail-
ability of sequence information also facilitates the de-
velopment of specific PCR-based or serological assays for
detection. Epidemiological screening of the distribution
of the candidate pathogen in diseased patients and
asymptomatic controls by PCR, as well as assessment
of the geographic and temporal distribution of infections,
can help in establishing a link to disease. Serology can also
play a critical role in determining pathogenicity, as
increases in titer support the association of a given
pathogen with infection. For example, serologic analyses
of a novel adenovirus species named ‘simian adenovirus C
(SAdV-C)’ associated with a pneumonia outbreak in a
baboon colony (Figure 4a) were recently used to establish
that staff personnel at the facility had also been exposed
to this newly discovered virus (Figure 4b) [105]. Finally,
development of a culture system and animal model for
infection can directly confirm that a candidate novel agent
plays a causal role in disease.
One advantage of using microarrays and NGS for
pathogen discovery is that these same technologies can
also be applied to evaluate the potential pathogenicity of
newly identified novel agents. Host transcriptome
analysis using gene expression microarrays [106] or
RNA-Seq [107] can enable the characterization of associ-
ated host biomarkers in response to infection. Detailed
NGS-based quasispecies analysis of novel pathogens that
exhibit high mutation rates, such as RNA viruses
[108,109], can also provide insights into how these agents
infect and invade the host.
Conclusions
Although sometimes derided as a ‘fishing expedition’,
pathogen discovery is, in actuality, a highly worthwhile
scientific endeavor. Without a cause identified for many
presumed infectious diseases, it is not possible to conduct
downstream investigations in pathogenesis and host–
microbial interactions, nor is it possible to design effective
vaccines or antimicrobial drugs to combat the associated
illness. Potential applications of pathogen discovery range
from outbreak investigation of emerging pathogens, to
screening of blood products, vaccines, and other biologics
for viral contaminants, to clinical diagnosis of unknown
acute or chronic infectious diseases. The current avail-
ability of state-of-the-art genomic technologies such as
pan-microbial microarrays and NGS provides an unpre-
cedented opportunity to ‘cast a wide net’ and survey the
full breadth of as-yet undiscovered pathogens in nature
that pose significant threats to human health.
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